|
|
Mechanisms of Cataplexy |
| 5R01NS106032-03 |
SCAMMELL, THOMAS E |
NHLBI |
2020 |
|
|
Characterization of a human in vitro blood-brain barrier model to study the effects of systemic aging on responses to Alzheimers disease effectors |
| 1 R21 AG065928-01 |
ERICKSON, MICHELLE A |
NIA |
2020 |
|
|
Development of NLRP3 inflammasome inhibitors towards Alzheimers disease |
| 3R01AG058673-03S1 |
ZHANG, SHIJUN |
NIA |
2020 |
|
|
Lead Exposure and Beta-Amyloid Transport by Brain Barriers |
| 3R01ES027078-03S1 |
ZHENG, WEI |
NIA |
2020 |
|
|
NWASP regulates neuroinflammation and cognition in Alzheimers disease |
| 3R01HL143017-03S1 |
DING, QIANG |
NIA |
2020 |
|
|
CORTICOSPINAL MECHANISMS FOR HIGH FAT DIET IMPEDING STROKE RECOVERY |
| 3R01NS114651-01S1 |
BOYCHUK, JEFFERY ALLEN |
NIA |
2020 |
|
|
Brain targeted nanoparticle for Alzheimers disease therapy |
| 5R01AG054839-04 |
XU, PEISHENG |
NIA |
2020 |
|
|
Modifiable cardiovascular factors linking type 2 diabetes and Alzheimers disease |
| 5R01AG055624-03 |
CONVIT, ANTONIO |
NIA |
2020 |
|
|
Development of Technologies to Increase In-Seat Movement to Prevent Sitting-Acquired Pressure Injuries in Wheelchair Users |
| 5R01AG056255-04 |
MORROW, MELISSA M |
NIA |
2020 |
|
|
Mechanisms of age-related susceptibility of NMJ function |
| 5R01AG057052-04 |
MANTILLA, CARLOS B |
NIA |
2020 |
